中华胰腺病杂志
中華胰腺病雜誌
중화이선병잡지
CHINESE JOURNAL OF PANCREATOLOGY
2013年
4期
248-251
,共4页
顾玉青%李占军%张静静%高文涛%钱祝银
顧玉青%李佔軍%張靜靜%高文濤%錢祝銀
고옥청%리점군%장정정%고문도%전축은
胰腺肿瘤%微RNAs%miR-200b%吉西他滨%上皮间质转化
胰腺腫瘤%微RNAs%miR-200b%吉西他濱%上皮間質轉化
이선종류%미RNAs%miR-200b%길서타빈%상피간질전화
Pancreatic neoplasms%MicroRNAs%miR-200b%Gemcitabine%Epithelial-mesenchymal transition
目的 探讨MicroRNA-200b (miR-200b)在吉西他滨诱导的胰腺癌MiaPaCa-2细胞上皮间质转化(EMT)过程中的作用.方法 应用不同浓度的吉西他滨诱导MiaPaCa-2细胞,选择50%细胞生长抑制时的药物浓度(IC50),获取耐药MiaPaCa-2细胞.采用脂质体法将miR-200b和无意义小分子片段(阴性对照)分别转染MiaPaCa-2细胞,再用IC50的吉西他滨诱导细胞,获取转染miR-200b的耐药MiaPaCa-2细胞及阴性对照的耐药MiaPaCa-2细胞.倒置显微镜下观察细胞形态变化;Transwell小室测定细胞侵袭能力;实时定量PCR检测细胞miR-200b表达;蛋白质印迹法检测细胞E-cadherin、Vimentin、Zeb1、Zeb2蛋白表达.结果 吉西他滨处理后细胞体积逐渐缩小,呈纺锤样,细胞间连接减少,伪足增多,呈现间质细胞特征.耐药MiaPaCa-2细胞的穿膜数从亲本细胞的(26±3)个上升至(85±6)个,Vimentin、Zeb1、Zeb2表达分别上升至亲本细胞的(1.87±0.17)、(2.57±0.21)、(5.24±0.83)倍,miR-200b表达下降至亲本细胞的(0.36±0.01)倍,E-cadherin表达下降至亲本细胞的(0.47±0.05)倍.而转染miR-200b的耐药MiaPaCa-2细胞的穿膜数下降至(42±4)个,Zeb1、Zeb2表达下降至阴性对照的耐药MiaPaCa-2细胞的(0.36±0.07)、(0.08±0.01)倍.结论 吉西他滨诱导胰腺癌MiaPaCa-2细胞过程中细胞出现EMT,其机制可能与miR-200b表达下调有关.
目的 探討MicroRNA-200b (miR-200b)在吉西他濱誘導的胰腺癌MiaPaCa-2細胞上皮間質轉化(EMT)過程中的作用.方法 應用不同濃度的吉西他濱誘導MiaPaCa-2細胞,選擇50%細胞生長抑製時的藥物濃度(IC50),穫取耐藥MiaPaCa-2細胞.採用脂質體法將miR-200b和無意義小分子片段(陰性對照)分彆轉染MiaPaCa-2細胞,再用IC50的吉西他濱誘導細胞,穫取轉染miR-200b的耐藥MiaPaCa-2細胞及陰性對照的耐藥MiaPaCa-2細胞.倒置顯微鏡下觀察細胞形態變化;Transwell小室測定細胞侵襲能力;實時定量PCR檢測細胞miR-200b錶達;蛋白質印跡法檢測細胞E-cadherin、Vimentin、Zeb1、Zeb2蛋白錶達.結果 吉西他濱處理後細胞體積逐漸縮小,呈紡錘樣,細胞間連接減少,偽足增多,呈現間質細胞特徵.耐藥MiaPaCa-2細胞的穿膜數從親本細胞的(26±3)箇上升至(85±6)箇,Vimentin、Zeb1、Zeb2錶達分彆上升至親本細胞的(1.87±0.17)、(2.57±0.21)、(5.24±0.83)倍,miR-200b錶達下降至親本細胞的(0.36±0.01)倍,E-cadherin錶達下降至親本細胞的(0.47±0.05)倍.而轉染miR-200b的耐藥MiaPaCa-2細胞的穿膜數下降至(42±4)箇,Zeb1、Zeb2錶達下降至陰性對照的耐藥MiaPaCa-2細胞的(0.36±0.07)、(0.08±0.01)倍.結論 吉西他濱誘導胰腺癌MiaPaCa-2細胞過程中細胞齣現EMT,其機製可能與miR-200b錶達下調有關.
목적 탐토MicroRNA-200b (miR-200b)재길서타빈유도적이선암MiaPaCa-2세포상피간질전화(EMT)과정중적작용.방법 응용불동농도적길서타빈유도MiaPaCa-2세포,선택50%세포생장억제시적약물농도(IC50),획취내약MiaPaCa-2세포.채용지질체법장miR-200b화무의의소분자편단(음성대조)분별전염MiaPaCa-2세포,재용IC50적길서타빈유도세포,획취전염miR-200b적내약MiaPaCa-2세포급음성대조적내약MiaPaCa-2세포.도치현미경하관찰세포형태변화;Transwell소실측정세포침습능력;실시정량PCR검측세포miR-200b표체;단백질인적법검측세포E-cadherin、Vimentin、Zeb1、Zeb2단백표체.결과 길서타빈처리후세포체적축점축소,정방추양,세포간련접감소,위족증다,정현간질세포특정.내약MiaPaCa-2세포적천막수종친본세포적(26±3)개상승지(85±6)개,Vimentin、Zeb1、Zeb2표체분별상승지친본세포적(1.87±0.17)、(2.57±0.21)、(5.24±0.83)배,miR-200b표체하강지친본세포적(0.36±0.01)배,E-cadherin표체하강지친본세포적(0.47±0.05)배.이전염miR-200b적내약MiaPaCa-2세포적천막수하강지(42±4)개,Zeb1、Zeb2표체하강지음성대조적내약MiaPaCa-2세포적(0.36±0.07)、(0.08±0.01)배.결론 길서타빈유도이선암MiaPaCa-2세포과정중세포출현EMT,기궤제가능여miR-200b표체하조유관.
Objective To investigate the role of miR-200b on gemcitabine induced epithelialmesenchymal transition (EMT) in pancreatic cancer cell line MiaPaCa-2.Methods Different concentrations of gemcitabine were used to induce MiaPaCa-2,and the concentration of 50% cell proliferation inhibited (IC50) was applied to obtain drug-resistant MiaPaCa-2 cells.MiR-200b or nonsense small molecular fragments (negative control,NC) was transfected into MiaPaCa-2 cells by liposomes,then gemcitabine of IC50 was used to induce cells to obtain drug-resistant MiaPaCa-2 cells transfected with miR-200b or NC.The morphological characteristics of MiaPaCa-2 cells were observed by inverted microscope.Invasion of cells were detected by transwell chamber.The expression of miR-200b was measured by using real-time PCR.The expressions of Ecadherin,Vimentin,Zebl,Zeb2 proteins were determined by Western blot.Results After gemcitabine treatment,the cells' size gradually diminished,intercellular junctions decreased,pseudopodium increased,which presented the characteristics of mesenchymal morphology.The invaded cell number increased from (26 ± 3) to (85 ± 6),and the expression of Vimentin Zebl,Zeb2 was increased to (1.87 ± 0.17),(2.57 ±0.21),(5.24 ± 0.83) folds of the parent cells.The expression of miR-200b was decreased to (0.36 ± 0.01)folds of the parent cells,and the expression of E-cadherin was decreased to 0.47 ± 0.05 folds of the parent cells,while the invaded cell number of drug-resistant MiaPaCa-2 transfected with miR-200b was decreased to (42 ± 4),and the expression of Zebl,Zeb2 was decreased to (0.36 ± 0.07),(0.08 ± 0.01) folds of drugresistant MiaPaCa-2 transfected with NC.Conclusions The occurrence of EMT is observed in pancreatic cancer cell line MiaPaCa-2 during gemcitabine induction,and miR-200b down-regulation may be a possible mechanism.